Human mesenchymal stem cells (hMSC) are a promising cell source for several applications of regenerative medicine. The cells employed are either autologous or allogenic; by using stem cell lines in particular, allogenic cells enable the production of therapeutic cell implants or tissue engineered implants in stock. For these purposes, the generally small initial cell number has to be increased; this requires the use of bioreactors, which offer controlled expansion of the hMSC under GMP-conform conditions. In this study, divided into part A and B, a fixed bed bioreactor system based on non-porous borosilicate glass spheres for the expansion of hMSC, demonstrated with the model cell line hMSC-TERT, is introduced. The system offers convenient automation of the inoculation, cultivation, and harvesting procedures. Furthermore, the bioreactor has a simple design which favors its manufacturing as a disposable unit. Part A is focused on the inoculation, cultivation, and harvesting procedures. Cultivations were performed in lab scales up to a bed volume of 300 cm 3 . The study showed that the fixed bed system, based on 2-mm borosilicate glass spheres, as well as the inoculation, cultivation, and harvesting procedures are suitable for the expansion of hMSC with high yield and vitality. original article allogenic stem cells, especially stem cell lines, allows in stock production of therapeutic cell implants.
INTRODUCTION
Due to their multipotency, mesenchymal stem cells can differentiate into various cell types like chondrocytes, neurocytes, myocytes, or osteocytes (1, 2) and are thus in the focus of clinicians and researchers. Autologous as well as allogenic cells can be used for regenerative medicine, although allogenic cells have to be encapsulated to protect them from the host immune system. However, the use of Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier -Part A: Inoculation, cultivation, and cell harvest procedures Weber et al TERT with high yield and vitality. Cultivations were performed in three different scales up to 300 cm 3 and with cell densities up to 2.9 x 10 6 cells/cm 3 . The cultivation process was mathematically modeled in part B of this study. This enabled the theoretical scale-up of the fixed-bed system which was done for a target cell number of 20 billion. Celldependent, temporal oxygen profiles were used for monitoring of the cultivation status. Growth and consumption kinetics were determined by fitting model parameters to the experimental data and from separate experiments in 6-well cell culture plates in order to verify the model.
MATERIALS AND METHODS
All chemicals were obtained from Sigma-Aldrich (Deisenhofen, Germany) unless otherwise indicated. The hMSC-TERT cell line was provided by the CellMed Ag (Alzenau, Germany). The passage numbers throughout the experiments were between 65 and 85. All deviations resulting from repeated parallel experiments were expressed as standard deviation. Error propagations were considered using the Gaussian error propagation law. Statistical significance was checked by Students t-test.
The fixed-bed reactor system
The lab-scale fixed-bed reactors up to a bed volume V FB of 60 cm 3 consisted of commercial glass syringes with special inserts, which replaced the original pistons (Figs. 1a and b) (20) . This perforated funnel-shaped insert, made of PEEK, provided a hose connector and thus enabled the perfusion of the packed beds with a homogenous inflow. A second custom-made system used for the 300 cm 3 scale was composed of a glass tube that was placed between stainless-steel lid and bottom plates (Fig. 1c ). These plates offered tube connections for the medium inlet and outlet. A funnel shape insert for spreading of the incoming medium made of stainless steel was placed in the inlet region. In both systems, a stainless-steel mesh prevented the fixed bed from entering the inlet tubing (Fig. 1a) .
The fixed-bed reactors comprised non-porous borosilicate glass spheres with a diameter of 2 mm. This means a volume specific growth surface A FB / V FB of 18.3 cm 2 /cm 3 . A preliminary carrier screening with several porous and nonporous carriers revealed that non-porous borosilicate glass spheres of 2 mm diameter are most suitable with respect system in GMP-conform processes. Additional important points concern the online monitoring of the cultivation status and the possibility of process automation.
A variety of bioreactor systems for the cultivation of diverse stem cell types have been described. They can be categorized into static culture systems, often performed in cell culture plates or T-flasks (3-6), suspension reactors like spinner flasks (4, 7-9), stirred tanks or rotary bioreactors (6, 10-12), and perfusion reactors (4, (13) (14) (15) (16) . Suspension and perfusion reactors require carrier or matrix systems which offer a suitable growth surface for the anchoragedependent cells. Cultivations of mesenchymal stem cells were performed in T-flasks, in spinner flasks containing microcarrier (Cytodex ® 1 and 3) (8), in rotary bioreactors (11), and in special reactors for stimulating the chondrogenic and osteogenic differentiation of encapsulated cells (4, 17). The disadvantage of using static culture systems is the large labor input due to the intricate automation of the inoculation, cultivation, and harvesting procedures. Better automation is feasible in suspension reactors, but the harvesting procedure, and especially the separation process of the cells from the carrier, is still intricate and requires additional devices. This drawback can be overcome by using fixed-bed reactors based on a non-porous carrier. The non-porosity supports the separation of enzymatically detached cells from the immobilized carrier by flushing them out with the medium flow. Fixed-bed reactors can be simply designed, favoring their production as disposable units. Additionally, automation and process monitoring can be easily realized.
Up until now, no cultivation of hMSC in fixed-bed reactors in order to expand the initial cell number has been described. This work introduces an axial fixed-bed reactor system for the cultivation of hMSC designed to satisfy the previously described requirements. The fixed-bed is based on non-porous borosilicate glass spheres with a diameter of 2 mm. These carriers are the most suitable for the nutrient supply and harvesting procedure, as shown previously (18).
The cells employed are human mesenchymal stem cells (hMSC), which are genetically modified with the gene of the catalytic subunit of human telomerase (TERT). This telomerase activity counteracts the shortening of the telomeres that occurs at each cleavage and thus leads to a permanent cell line (19) .
Inoculation, cultivation, and harvesting procedures were developed, enabling the automated generation of hMSC-Expansion of hMSC in a fixed-bed bioreactor -Part A tor system was operated in a humidified incubator at 37°C and 5% CO 2 . The medium was aerated in the conditioning vessel by surface aeration.
Static cell culture of hMSC-TERT

Cultivation in T-flasks
Stocks were thawed in a 37°C water bath until ice crystals completely disappeared. Afterwards, cell suspensions to growth, cell harvest, and nutrient supply (18).
Three flasks equipped with sterile air filters for pressure compensation were connected to the fixed-bed reactor and acted as conditioning, inoculum, waste, and collecting vessel (Fig. 1d ). The waste vessel contained the inoculum prior to the inoculation procedure. Oxygen concentration was measured in the medium inlet and outflow using noninvasive oxygen sensors (Fibox 3; PreSens Precision Sensing GmbH, Augsburg, Germany). Medium was perfused by means of a peristaltic pump (IPC-8; Ismatec SA, Glattbrugg, Switzerland) and directed using pinch valves (100P NC 24-05; msscientific GmbH, Berlin, Germany). The reac- Dynamic cell culture of hMSC-TERT in the fixed bed systems
Inoculation procedure
The inoculation procedure was performed in different ways. Using the first method, a 14.2 cm 3 fixed bed was filled with cell suspension (10,000 cells per cm 2 growth surface area) and incubated for 90 minutes without perfusion. This method was then modified in order to return settled, nonadhered cells into the fixed bed and thus increase the yield of adherent cells. To do this, the fixed bed was perfused for 7 minutes at a superficial velocity n of 1.2 x 10 -4 m s -1 after time intervals of 30 minutes. This cycle was repeated two or four times, so that the overall durations of these inoculation procedures were 104 and 178 minutes. The perfusion time was calculated from the fixed bed height h FB , the superficial velocity n, and the factor 1.1, which means an overlap of the cell suspension over the fixed bed of 10%:
Eq. 5
During the 30-minute phases without perfusion, the valve V1 ( Fig. 1c ) was closed to prevent sedimentation of cells into the tubing. After the inoculation procedure, the fixed bed was rinsed with medium so as to get rid of non-adherent cells. The fixed beds were removed in layers to represent the axial cell density distribution. For determination of the cell number, nuclei were counted using a Neubauer hematocytometer after lysis of the cells with citric acid and staining with crystal violet, as previously described (21). The experiments were performed in triplicate.
were diluted in culture medium, which consisted of Eagle's Minimal Essential Medium (EMEM; Biochrom, Berlin, Germany), supplemented with 10% fetal calf serum (FCS; Biowest, Nuaillé, France), at room temperature and centrifuged at 230 x g. After decantation of the supernatants, cells were resuspended in fresh medium, seeded into T300-flasks at a cell density of 5000 cells/cm 2 , and cultured with 75 mL medium in a humidified incubator at 37°C and 5% CO 2 until a cell density of approximately 150,000 cells/cm 2 was reached. Medium was exchanged after three days of cultivation. Harvesting of cells was carried out by adding 0.05 ml/cm 2 trypsin-EDTA solution, incubation for 5 minutes, and rinsing of the flasks with medium to stop the enzymatic reaction. Cells were used for experiments or subcultivated in T300-flasks after centrifugation and resuspension in medium.
Determination of growth and glucose consumption kinetics in 6-well cell culture plates
A Monod kinetic limitation by glucose was assumed. For determination of the dependency of the growth rate and glucose consumption rate on the glucose concentration, four 6-well cell culture plates were inoculated with 5000 cell/cm 2 and cultured with 1 mL medium per well for eight days. Three wells were harvested daily and the cell numbers as well as the glucose concentrations were determined. The growth rate at each time interval j = 1, 2, 3 … n was calculated by:
This equation is only valid for the log phase of the cell growth, which was determined by taking the logarithm of the growth curve.
The glucose consumption was related to the logarithmic mean of the cell density in order to obtain the cell specific glucose consumption rate:
Eq. 2 with the surface A, the glucose concentration ϲ Glc , and ) ) Expansion of hMSC in a fi xed-bed bioreactor -Part A The cell numbers at the time points were calculated using the oxygen concentration difference between the inlet and outlet , the oxygen consumption rate as well as the volume fl ow rate
For simplifi cation, the oxygen uptake kinetic was considered independent from the concentration and calculated with the oxygen difference between the medium inlet and outlet at the end of the fi xed bed cultivation:
is the cell number counted at the end of cultivation, is the associated oxygen concentrations in the conditioning vessel and thus in the inlet of the fi xed bed and is the outlet concentration. From the cell densities , calculated with the cell number and the fi xed-bed volume V FB , the initial cell density and the mean growth rate µ m were obtained by the curve fi tting:
Eq. 8
The mean glucose consumption rate was calculated by the following equation
Eq. 9
Infl uence of the superfi cial velocity on the growth rate Due to the non-porosity of the carrier, the cells are totally exposed to shear stress caused by the medium fl ow. This demands a determination of an upper limit for the superficial velocity n, which is important for an up-scaling of the process (see part B of this publication). The criterion used is the point at which the mean growth rate µ m starts to decrease.
The investigations were carried out in four parallel-operated 14.2 cm 3 fi xed-bed reactors. For this, fi xed beds were inoculated as described above with 1.83 x 10 5 cells/ cm 3 (10 4 cells/cm 2 ) and cultivated at three different superficial velocities n. For more details of these cultivations see Table I . After cultivation, the fi xed beds were removed in layers to represent the axial cell-density distribution. Cell densities were determined by crystal violet staining of the nuclei at the end of the cultivations (21). The mean growth rates were calculated according to Equation 1.
Cultivation in different fi xed-bed scales
In addition to the cultivation in 14.2 cm 3 fi xed-bed reactors as described above, cultivations in 60 cm 3 and 300 cm 3 scale were performed. The reactors were inoculated with 1.3 x 10 5 cells/cm 3 (7 x 10 3 cells/cm 2 ) and 1.8 x 10 5 cells/cm 3 (10 x 10 3 cells/cm 2 ), respectively, but it has to be noted that this was not the initial cell density, since only 50% of the inoculated cells got attached to the carrier, as will be shown subsequently. More details about the cultivations are given in Table I . Cell densities were calculated from the oxygen consumption and determined by counting the nuclei after cell lysis and crystal violet staining.
• 
Evaluation criteria for the harvesting procedures were the yield, which is defi ned as the number of detached cells to the overall cell number in the fi xed bed, and the vitality, which is defi ned as the ratio of living cells to the total number of detached cells. Vitality was measured with the trypan blue exclusion method.
RESULTS AND DISCUSSION
Growth and glucose uptake kinetics in 6-well cell culture plates
The glucose-dependent growth and glucose consumption kinetics in static culture were obtained by fi tting Equations 3 and 4 to the growth or consumption rate versus glucose concentration curves ( Figs. 2 and 3) . The maximal growth rate µ max and the Monod constant were found to be 0.66 ± 0.02 d -1 and 0.14 ± 0.03 mg mL -1 . The maximal glucose uptake rate was (7.7 ± 1.1) x 10 -8 mg h -1 cell -1 with the according Monod constant = 0.16 ± 0.06 mg mL -1 .
It was assumed that glucose is the limiting medium component. This assumption is corroborated by the fact that the curve in Figure 3 passes the origin of the coordinates. A limitation by other nutrients like glutamine would shift the intersection with the x-coordinate. In addition, glutamine has been reported to be an unimportant energy source for human, goat, and rat mesenchymal stem cells (22).
with the medium volume in the conditioning vessel V CV , the cultivation duration t n , and the log mean of the cell density Eq. 10
Harvesting procedure
Investigations for the cell harvesting were performed in 14.2 cm 3 fi xed-bed reactors at a cell density of about 10 5 cells/cm 2 . Accutase TM was mainly chosen because it is less harmful to the cells compared to trypsin. The investigated methods can be divided into two classes:
The enzyme solution and with it the detached cells were perfused cyclically with a comparably high superfi cial velocity n.
The enzyme solution was perfused at lower velocity and directly led to the collecting vessel. Then the detached cells were fl ushed out by means of perfusion of the fi xed bed with medium at higher velocity, which was also directed to the collecting vessel.
The second procedure is assumed to be more gentle because it avoids recirculation of detached cells, leading to less shear stress. More details about the harvesting experiments are given in Table II . In order to avoid inhibiting effects of the serum to the enzyme activity, the fi xed beds were rinsed with 100 mL PBS in each case prior to enzymatic treatment. tion of the medium at the highest cell density of 6.3 x 10 4 cells cm -2 using an oxygen transfer coeffi cient of 0.184 m h -1 (23) and an oxygen consumption rate of 2 x 10 -8 mg h -1 cell -1 leads to a saturation of about 99%. Assuming a higher oxygen consumption rate of 4 x 10 -8 mg h -1 cell -1 would only reduce the oxygen saturation to about 97 %. Tables III and IV give some examples of published growth and glucose consumption kinetics of several animal and The relation of lactate to consumed glucose is 2.74 mol/ mol. This points to an ineffi cient metabolism of glucose for energy mainly via glycolysis. also reported a high lactate/glucose ratio of up to 2.13 mol/mol in the cultivation of hMSC (22).
An oxygen limitation during the cultivation in cell culture plates can be excluded because of the high surface area to cell number relation. An estimation of the oxygen satura- A mean growth rate µ m of 0.62 d -1 is close to the maximal growth rate µ max of 0.66 d -1 , determined in static culture in 6-well cell culture plates, which can only be reached by an infinite glucose concentration because of the Monod kinetic. Therefore it may be assumed, that a further decrease of superficial velocity n would not lead to a significant increase in growth rate. For all of the subsequently performed cultivations, the rounded superficial velocity n of 3.0 x 10 -4 m s -1 was used.
Cultivation of hMSC-TERT at different fixedbed scales
hMSC-TERT were cultured in scales V FB of 14 cm 3 , 60 cm 3 , and 300 cm 3 . Figures 6 to 8 show the experimental data. The results are summarized in Table V. The cells were cultured up to a density of (2.93 ± 0.11) x 10 6 cells/cm 3 . Higher cell densities are not recommendable because of the risk of channeling and drawbacks by up-scaling of the fixed bed system, as shown in part B of this publication. The initial cell densities and were about 50% to 60% of the inoculated cell densities, which confirms the results of the inoculation procedure.
The mean growth rate µ m and the oxygen consumption rate decreased with advancing passage number from 0.60 to 0.42 d -1 and 2.03 x 10 -8 to 1.08 x 10 -8 human cells or cell lines. The kinetics determined in this work are in the same range of those reported values.
Cultivation in fixed-bed reactors
Inoculation procedure
The yield of adherent cells after the inoculation procedure could have been increased by repeated perfusion of the fixed bed from 35%, without perfusion, to 49% (Fig.  4) . No tendency dependent on the inoculation strategy regarding the axial cell distribution could be detected.
Additional perfusion steps, other superficial velocities n, or time intervals between the perfusion steps could lead to a further enhancement of the yield of adherent cells. Thus, further studies are recommended.
Influence of the superficial velocity on the growth rate
The mean growth rate µ m in the exponential phase decreases from 0.62 ± 0.01 d -1 at a superficial velocity n of 2.65 x 10 -4 m s -1 to 0.29 ± 0.01 d -1 at a superficial velocity of 1.59 x 10 -3 m s -1 (Fig. 5) . A flow velocity dependent trend in axial cell distribution could not be observed. Expansion of hMSC in a fixed-bed bioreactor -Part A mg h -1 cell -1 , respectively, whereas the mean glucose consumption rate increased from 7.65 x 10 -8 to 9.50 x 10 -8 mg h -1 cell -1 . Although hMSC-TERT are considered to be a permanent cell line, changes in growth and consumption kinetics occur within 17 passages. A decrease of growth rate with advancing passage number has been reported for other cells like hMSC or adipose stem cells (rhesus monkey) (24, 25). One consequence of this is that an optimized process design is only valid for a closed range of passage numbers.
All kinetics are within the range of those reported for several animal and human cells or cell lines (Tabs. III, IV and VI).
For the oxygen uptake, a zero order kinetic was assumed. This assumption is valid for oxygen saturation above 20% and thus for the performed cultivation runs (26). Furthermore, in part B of this study the constants of the growth kinetic µ max and were determined by fitting model parameters to the experimental data of the fixed-bed cultivations (27) . Comparing the constants of the cultivation in the 14 cm 3 scale (passage number=68) Tab. II). The vitality was 84%. Better results were obtained with non-cyclic perfusion of the enzyme solution and fl ushing out of the cells in the fi xed bed for a short perfusion time with a comparably high superfi cial velocity ( Fig. 9 , procedure d-i; Tab. II). Treatment of the cells with Accutase TM solution for 10 minutes and a superfi cial velocity n of 1.8 x 10 -4 m s -1 followed by perfusion with medium for 2 minutes and a superfi cial velocity of 3.2 x 10 -3 m s -1 resulted in a yield of (82.1 ± 2.3)% and a vitality of (96.5 ± 0.7)%. Altogether, non-cyclic perfusion led to higher vitalities compared to cyclic perfusion, which is explainable by the reduced shear stress due to nonrepeated passage of already detached cells through the system components.
to those of the cultivation in 6-well cell culture plates (passage number=69) of this publication, no signifi cant deviation in K M,µ Glc occurred. This suggests that the oxygen saturation has a negligible effect on the growth kinetic, at least in the range of 35% to 100%. Otherwise the observable Monod constant K M,µ Glc for the glucose dependence of the growth rate would be wrongly increased.
Harvesting procedure
Increasing the superfi cial velocity n of the cyclic perfused Accutase TM solution from 8.0 x 10 -4 to 3.2 x 10 -3 m s -1 and extending the residence time from 10 to 20 minutes enhanced the yield from 5% to 76% (Fig. 9 , procedure a-c; Expansion of hMSC in a fixed-bed bioreactor -Part A ciple a carrier-filled tube connected to a conditioning vessel, enables production of this system as a disposable unit. Easy automation and comfortable process monitoring by measuring the oxygen concentration at the inlet and outlet or glucose concentration in the conditioning vessel, for example, favor the transfer of this system into a GMP-process.
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CONCLUSIONS
The fixed-bed reactor concept based on non-porous borosilicate glass spheres introduced in this paper is suitable for the cultivation of hMSC-TERT. An application of the system for the cultivation of non-modified hMSC is theoretically feasible.
The introduced inoculation, cultivation, and harvesting procedures are designed for an automated performance of hMSC-TERT expansion with high yield and vitality of the harvested cells.
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